<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33722829</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1488-2329</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>193</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
          <ISOAbbreviation>CMAJ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Guillain-Barré syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>E378</StartPage>
          <MedlinePgn>E378</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.202710</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mirian</LastName>
            <ForeName>Ario</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, London, Ont. ario.mirian@lhsc.on.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nicolle</LastName>
            <ForeName>Michael W</ForeName>
            <Initials>MW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, London, Ont.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Budhram</LastName>
            <ForeName>Adrian</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, London, Ont.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>CMAJ</MedlineTA>
        <NlmUniqueID>9711805</NlmUniqueID>
        <ISSNLinking>0820-3946</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33722829</ArticleId>
        <ArticleId IdType="pmc">PMC8096408</ArticleId>
        <ArticleId IdType="doi">10.1503/cmaj.202710</ArticleId>
        <ArticleId IdType="pii">193/11/E378</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sejvar JJ, Baughman AL, Wise M, et al. . Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology
2011;36:123–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5703046</ArticleId>
            <ArticleId IdType="pubmed">21422765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baxter R, Bakshi N, Fireman B, et al. . Lack of association of Guillain–Barré syndrome with vaccinations. Clin Infect Dis
2013;57:197–204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23580737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonhard SE, Mandarakas MR, Gondim FAA, et al. . Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol
2019;15:671–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6821638</ArticleId>
            <ArticleId IdType="pubmed">31541214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes RA, Wijdicks EF, Barohn R, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain–Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology
2003;23:736–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14504313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Berg B, Storm EF, Garssen MJP, et al. . Clinical outcome of Guillain–Barré syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry
2018;89: 949–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29627773</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
